期刊文献+
任意字段
题名或关键词
题名
关键词
文摘
作者
第一作者
机构
刊名
分类号
参考文献
作者简介
基金资助
栏目信息

乳腺癌的内分泌治疗进展 被引量：4

THE DEVELOPMENT IN ENDOCRINE THERAPY OF BREAST CANCER
下载PDF
导出
摘要 乳腺癌的内分泌治疗是通过体内激素水平的改变,影响肿瘤的发生和发展的疗法,它对雌孕激素阳性乳腺癌患者的治疗效果十分显著,且副作用较小。近年来,内分泌治疗已经成为乳腺癌治疗方法中的研究热点。 Endocrine treatment of breast cancer affects the occurrence and development of cancer therapies through the body changes in hormone levels, which has quite remarkable results in estrogen and progesterone positive breast cancer patients, and fewer side effects. In recent years, endocrine therapy has heeome the hotspot in the treatment of breast cancer.
作者 刘宁 王可人 孙光 续哲莉
机构地区 吉林大学中日联谊医院乳腺甲状腺外科
出处 《内蒙古农业大学学报（自然科学版）》 CAS 北大核心 2010年第1期294-300,共7页 Journal of Inner Mongolia Agricultural University(Natural Science Edition)
关键词 乳腺癌 内分泌治疗 Breast cancer endocrine therapy
分类号 R737.9 [医药卫生—肿瘤]
  • 相关文献

参考文献54

  • 1Fisher B, Costantino JP, Wickerham DL, et al. Tamoxifen for prevention of breast cancer:report of the National Surgical Adjuvant Breast and Bowel Project P21 Study [ J ]. J Natl Cancer inst, 1998,90(18) : 1371 - 1388.
  • 2Waeber M, Castiqlione Gertsch M, Dietrich D, et al. Adjuvant therapy after excision and radiation of isolated post- mastectomy locoregional breast cancer recurrence:definitive results of a phase HI randomized trial (SAKK23/82) comparing tamoxifen with observation. Ann Oncol, 2003, 14: 1215-1221.
  • 3Early Breast Cancer Trialists" Collaborative Group (EBCTCG). Effects of chemotherapy and hormonal therapy for early breast cancer on recurrence and 15 - year survival:an overview of the randomised trials [ J ]. Lancet, 2005,365 (9472) :1687 - 1717.
  • 4Fisher B, Dignam, Bryant J, et al. Five versus more than five years of tamoxifen for lymphnode - negative breast cancer:updated findings from the National Surgical Adjuvant Breast and Bowel Project B - 14 randomized trial [J]. J Nail Cancer Inst ,2001,93 (9) :684 -690.
  • 5R. Peto. ATLAS (adjuvant tamoxifen, longer against shorter) :International randomized trim of 10 vs 5 years of adjuvant tamoxifen among 11500 women- Preliminary resuhs. SABCS2007, Abstract#48.
  • 6吴洪斌.抗雌激素抗肿瘤新药托瑞米芬[J].中国临床药学杂志,2001,10(4):253-254. 被引量：9
  • 7顾振鹏.乳腺癌患者长期应用三苯氧胺后子宫内膜的变化[J].滨州医学院学报,2002,25(3):200-201. 被引量：19
  • 8Cummings SR, Eckert S, Krueget KA, et al. The effect of raloxifene on risk of breast cancer in postmenopausal women:results from the MORE randomized trial. Multiple Outcomes of Raloxifene Evaluation[J]. TAMA, 1999,281 (23) :2189 -2197.
  • 9王佳玉,徐兵河.乳腺癌内分泌治疗新药fulvestrant临床研究进展[J].癌症进展,2005,3(4):342-344. 被引量：8
  • 10Howell A, Robertson JF, Quaresma Albano J, et al. Fulvestrant,foremerly ICI182,780, is as effective as anastrozole in postmenopausal women with advanced breast cancer progressing after prior endocrine treatment [ J ]. J Clin Oneol, 2002, 20(16):3365-3368.

二级参考文献52

  • 1孟洁,张瑾.年轻女性乳腺癌临床资料分析[J].中国肿瘤临床,2006,33(22):1316-1320. 被引量：37
  • 2[1]Neven P,Shepherd JH,Lowe DG.Tamoxifen and gynecologist[J].Br J Obstet Gynecol,1997;100:895
  • 3[2]Elkas J,Gray K,Howard L,et al.The effects of tamoxifen on endometrial insulin-like growth factor-1 expression[J].Obstet Gynecol,1998;91(1):45
  • 4[3]Cohen I,Beyth Y,Altaras MM,et al.Estrogen and progesterone receptor expression in postmenopausal tamoxifen-exposed endometrial pathologies[J].Gynecol Oncol,1997;67(1):8
  • 5[4]Fotiou S,Tserkezoglou A,Hdjieleftheriou G,et al.Tamoxifen associated utrine pathology in breast cancer patients with abnormal bleedding[J].Antiancer Res,1998;18(1B):625
  • 6[5]Hulka CA,Hall DA.Endometrial abnormalities associated with tamoxifen therapy for breast cancer:sonographic and pathologic correlation[J].AJR Am J Roentgenol,1993;160(4):809
  • 7[6]Chen WF,Lin HH,Torng PL,et al.Comparison of endometrial changes among symptomatic tamoxifen-treated and nontreated premenopausal and postmenopausal breast cancer patients[J].Gynecol Oncol,1997;66(2):233
  • 8[7]Daniel Y,Inbar M,Bar-Am A,et al.The effects of tamoxifen treatment on the endometrium[J].Fertil Steril,1996;65:1083
  • 9[8]Seoud MA,Johnson J,Weed JC Jr.Gynecologi caltumors in tamoxifen treated with breast cancer[J].Obstet Gynecol,1993;82(2):165
  • 10[9]Katase K,Sugiyama Y,Hasumi K,et al.The incidence of subsequent endometrial carcinoma with tamoxifen use in patients with primary breast carcinoma[J].Cancer,1998;82(9):1698

共引文献58

同被引文献79

引证文献4

二级引证文献11

内蒙古农业大学学报（自然科学版）
2010年 第1期

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部